Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Gerald H. Clamon, MD

Dr. Clamon
Iowa City, IA

Dr. Gerald H. Clamon

Medical Oncologist

Holden Comprehensive Cancer Center

University of Iowa Hospitals & Clinics
200 Hawkins Drive
Iowa City, IA 52242
800.777.8442

Need Help Contacting This Doctor?

Dr. Clamon has various specialties, including lung cancers. He has been affiliated with the esophageal cancer, lung cancer, and head and neck cancer clinics at the Holden Comprehensive Cancer Center at the University of Iowa Hospitals and Clinics, the only NCI-designated comprehensive center in the state of Iowa. Much of Dr. Clamon's expertise can be seen through his publications, many of which focus on lung cancers.

Main Specialty: Oncology

Other Interests & Specialties: Hematologic oncology, general oncology, esophageal cancer, lung cancer, and head and neck cancers.

Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology

Education & Experience:

Publications:
High-dose paclitaxel plus G-CSF for malignant mesothelioma. Annals of Oncology. May 1999;10(5):597–600. doi: 10.1023/A:1026438215309

Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer. Journal of Clinical Oncology. July 1985; 3(7): 949-957. doi: 10.1200/JCO.1985.3.7.949

Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung. Cancer. June 1984;53(9):1852-6. doi: 10.1002/1097-0142(19840501)53:93.0.CO;2-F

Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial. Cancer Treatment Reports. February 1985;69(2):166-67.

Chemoprevention and screening for lung cancer: changing our focus to former smokers. Clinical Lung Cancer. January 2015;16(1):1-5. doi: 10.1016/j.cllc.2014.09.009

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. Journal of Clinical Oncology. November 2013;31(33):4179-4187. doi: 10.1200/JCO.2013.49.2173

Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients. World Journal of Gastrointestinal Oncology. May 2012;4(5):103-108. doi: 10.4251/wjgo.v4.i5.103

Advances in the systemic treatment of leptomeningeal cancer. Clinical Advances in Hematology & Oncology. March 2012;10(3):166-170.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. Journal of Clinical Oncology. May 2010;28(13):2181-2190. doi: 10.1200/JCO.2009.26.2543

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide